Abstract
Preimplantation genetic diagnosis (PGD) has been an invaluable tool in the study of increased aneuploidy rates with oocytes from older patients. The technique is however labor intensive , requires expertise and necessitates growth of the embryo in vitro to the blastocyst stage. Moreover, embryonic mosaicism may result in misdiagnosis and discarding of normal embryos. Thus, the use of preimplantation genetic diagnosis for aneuploidy has been recommended primarily for patients with a larger pool of embryos.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
